Arrhythmia

Featured Article

A 32-Year-Old Man Experiences Syncope After Camping

A 32-Year-Old Man Experiences Syncope After Camping

Several weeks after camping, a 32-year-old man experiences syncope while driving to an urgent care center to address his worsening symptoms of fatigue.

Latest Features

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Using digital adherence devices to improve medication adherence in patients with atrial fibrillation may reduce the rate of ischemic strokes.

Sudden Death in Young Athletes: Screening, Risk Factors, and Prevention

Sudden Death in Young Athletes: Screening, Risk Factors, and Prevention

Evaluating screening and prevention for sudden death in young athletes.

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

Atrial Fibrillation: Updates in Screening, Surgical Ablation, and Anticoagulation Use

Atrial Fibrillation: Updates in Screening, Surgical Ablation, and Anticoagulation Use

Anticoagulation under- and overdoing can be problematic in patients with atrial fibrillation.

Understanding Obesity's Role in Atrial Fibrillation

Understanding Obesity's Role in Atrial Fibrillation

The comorbid conditions of obesity and atrial fibrillation require better prevention and treatment strategies.

Weighing Benefits and Risks of Anticoagulation in the Elderly

Weighing Benefits and Risks of Anticoagulation in the Elderly

Determining which patients who have atrial fibrillation should receive anticoagulation therapy for stroke prophylaxis can be challenging.

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

Premature Ventricle Contractions in Heart Failure: A Closer Examination

Premature Ventricle Contractions in Heart Failure: A Closer Examination

A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.

Latest News

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Complete reversal was seen within 4 hours in the majority of patients, as measured by ecarin clotting time (ECT 82%) or diluted thrombin time (dTT 99%). In addition, there was a low late of thrombotic events and no new safety events were reported.

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.

Influenza Vaccination May Reduce Mortality Risk in Heart Failure

Influenza Vaccination May Reduce Mortality Risk in Heart Failure

A meta-analysis sought to determine the effect of influenza vaccination on cardiac-related mortality in patients with heart failure.

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation

Patients with persistent atrial fibrillation who received targeted therapy saw improvements in sinus rhythm as well as reductions in blood pressure, cholesterol, and weight.

Device Recall: HeartStart MRx Defibrillator Gas Chamber Tube Defect

Device Recall: HeartStart MRx Defibrillator Gas Chamber Tube Defect

The HeartStart MRx defibrillator may fail at any time, including during repeated shocks while in AED mode.

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.

CPR: Updated Treatment Consensus From International Liaison Committee on Resuscitation

CPR: Updated Treatment Consensus From International Liaison Committee on Resuscitation

The International Liaison Committee on Resuscitation released an updated consensus on cardiopulmonary resuscitation and emergency cardiovascular care.

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.

Sign Up for Free e-Newsletters